| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/08/2000 | US6022546 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 02/08/2000 | US6022543 Hepatitis B surface antigen vaccine |
| 02/08/2000 | US6022542 Polypeptide which serves as reagent in diagnostic kit for detecting an anti-herpesvirus antibody present in a biological sample; kaposi's sarcoma (ks) and retroperitoneal fibromatosis (rf) |
| 02/08/2000 | US6022540 Ligands that modulate differentiation of mesenchymal stem cells |
| 02/08/2000 | US6022535 Administering human interleukin-3 variant or mutant proteins (muteins) fused with other colony stimulating factors, cytokines, lyphokines, interleukins, hematopoietic growth factors; treating side effects of cancer radiation therapy |
| 02/08/2000 | US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 02/08/2000 | US6022520 Administering a diagnostic amount of a radiolabeled reagent capable of inhibiting human platelet aggregation comprising radiolabel complexing moiety and a platelet glycoprotein iib/iiia-binding compound covalently linked to the moiety |
| 02/08/2000 | US6022242 Connector used for flexible flat cable |
| 02/08/2000 | CA2183552C Methods for controlling sialic acid derivatives in recombinant glycoproteins |
| 02/08/2000 | CA2003794C Expression of hiv proteins in drosophila cells |
| 02/07/2000 | CA2363505A1 Method for shortening internode of inflorescence by introducing gene for petunia transcription factor petspl2 |
| 02/07/2000 | CA2244234A1 Method for shortening internode of inflorescence by introducing gene for petunia transcription factor petspl2 |
| 02/03/2000 | WO2000005417A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 02/03/2000 | WO2000005414A1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination |
| 02/03/2000 | WO2000005413A1 Genetic polymorphism in a complement receptor |
| 02/03/2000 | WO2000005392A1 Method for transformation of animal cells |
| 02/03/2000 | WO2000005380A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 02/03/2000 | WO2000005379A1 Polynucleotide transporter protein |
| 02/03/2000 | WO2000005378A2 Streptococcus suis vaccines and diagnostic tests |
| 02/03/2000 | WO2000005377A2 Pc4 transcriptional coactivators |
| 02/03/2000 | WO2000005376A1 Pb 39, a gene dysregulated in prostate cancer, and uses thereof |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |
| 02/03/2000 | WO2000005374A2 Molecules associated with cell proliferation |
| 02/03/2000 | WO2000005373A2 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 02/03/2000 | WO2000005372A1 Human ion transport-like protein |
| 02/03/2000 | WO2000005371A1 Keratinocyte derived interferon |
| 02/03/2000 | WO2000005370A1 Orphan cytokine receptor |
| 02/03/2000 | WO2000005369A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 02/03/2000 | WO2000005368A1 Human calcium regulatory proteins |
| 02/03/2000 | WO2000005367A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 02/03/2000 | WO2000005366A2 Xiap ires and uses thereof |
| 02/03/2000 | WO2000005365A1 Human lcb kinase 1 |
| 02/03/2000 | WO2000005364A1 Protein similar to neuroendrocrine-specific protein, and encoding cdna |
| 02/03/2000 | WO2000005363A1 Method for screening of modulators of calcineurin activity |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005360A1 Sara proteins |
| 02/03/2000 | WO2000005356A1 Methods and compositions for inhibition of angiogenesis |
| 02/03/2000 | WO2000005348A1 Pneumococcal nrdg protein |
| 02/03/2000 | WO2000005346A1 Novel potassium channel molecules and uses therefor |
| 02/03/2000 | WO2000005345A1 Human thyrotropin receptor compositions and use thereof |
| 02/03/2000 | WO2000005266A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | WO2000005264A1 Novel g protein-conjugated receptor protein and dna thereof |
| 02/03/2000 | WO2000005263A2 Compounds for use in the treatment of inflammation |
| 02/03/2000 | WO2000005262A1 Uses of igf-i e domain peptides |
| 02/03/2000 | WO2000005261A1 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
| 02/03/2000 | WO2000005260A1 Peptide analogues of pacap |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005258A1 A crystal of a ras-sos complex and methods of use thereof |
| 02/03/2000 | WO2000005257A1 Pectic substance as a growth factor stabilizer |
| 02/03/2000 | WO2000005256A1 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
| 02/03/2000 | WO2000005255A2 Anti-inflammatory compounds |
| 02/03/2000 | WO2000005254A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 02/03/2000 | WO2000005253A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | WO2000005252A1 Vaccine comprising a non-toxic immunogenic derivative of clostridium botulinum type d neurotoxin |
| 02/03/2000 | WO2000005250A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000005248A1 Human gdf-3 nucleic acids, polypeptides, vectors, host cells, methods and uses thereof |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005241A1 Angiopoietin related gene sequence scarface 2 |
| 02/03/2000 | WO2000005240A1 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL46 |
| 02/03/2000 | WO2000004929A1 Use of decreasing levels of functional transient receptor potential gene product |
| 02/03/2000 | WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004921A1 Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine |
| 02/03/2000 | WO2000004919A2 Live attenuated salmonella vaccines to control avian pathogens |
| 02/03/2000 | WO2000004913A1 Fsh and fsh variant formulations, products and methods |
| 02/03/2000 | WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | WO2000004762A1 Regulation of circadian rhythms and flowering |
| 02/03/2000 | WO2000004761A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants |
| 02/03/2000 | WO2000004760A1 Copper transporter in ethylene signaling pathway |
| 02/03/2000 | WO1999067387A3 Novel mp-7 protein and nucleic acid molecules and uses therefor |
| 02/03/2000 | WO1999066057A3 Inducible promoters |
| 02/03/2000 | WO1999064602A3 Moraxella catarrhalis polynucleotides and polypeptides |
| 02/03/2000 | WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 02/03/2000 | WO1999064450A3 Cif130 inhibits cell cycle progression |
| 02/03/2000 | WO1999064448A3 Moraxella catarrhalis pilq proteins |
| 02/03/2000 | WO1999061475A8 Method for separating and/or isolating plasma proteins by annularchromatography |
| 02/03/2000 | WO1999061052A3 Oral immunization with papillomavirus virus-like particles |
| 02/03/2000 | WO1999060120A3 Soluble t cell receptor |
| 02/03/2000 | WO1999060119A3 Multivalent t cell receptor complexes |
| 02/03/2000 | WO1999060108A3 Transgenic animals produced by homologous sequence targeting |
| 02/03/2000 | WO1999059620A9 Angiostatin receptor |
| 02/03/2000 | WO1999058571A3 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 02/03/2000 | WO1999057536A9 Cyclin activation kinase (cak) from human pathogens, and uses related thereto |
| 02/03/2000 | WO1999057277A3 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/03/2000 | WO1999057142A3 Vaccine for $i(pseudomonas aeruginosa) |
| 02/03/2000 | WO1999057139A3 Pth2 receptor selective compounds |
| 02/03/2000 | WO1999054352A3 Srebp-1 and srebp-2 in a phosphorylated form |
| 02/03/2000 | WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/03/2000 | WO1999052945A9 NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF |
| 02/03/2000 | WO1999052942A3 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 02/03/2000 | WO1999051748A3 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/03/2000 | WO1999047638A3 Mutations in mitotic check point genes and methods of diagnosis |
| 02/03/2000 | WO1999037783A3 Live vaccine against brucellosis |
| 02/03/2000 | WO1999037764A3 New members of the glypican gene family |
| 02/03/2000 | DE19847779C1 Novel receptor DNA useful for identifying apoptosis-modulating substances potentially useful for cancer chemotherapy |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2714833A1 Vaccines against escherichia coli o157 infection |
| 02/03/2000 | CA2339045A1 Anti hepatitis c virus antibody and uses thereof |